SCHEMBL1714739

SCHEMBL1714739

COCCC(=O)CCC=O

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
APEX1 P27695 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1714308 0.98 ALDH1A1 (0.34) ALDH1A1MAPTHPGDTSHR
SCHEMBL1714217 0.98 ALDH1A1 (0.34) ALDH1A1MAPTHPGDTSHR
SCHEMBL4267041 0.83 ALDH1A1 (0.46) ALDH1A1HPGDTSHRAPEX1
SCHEMBL27277948 0.80 ALDH1A1 (0.44) ALDH1A1HPGDTSHRAPEX1
SCHEMBL9618343 0.80 HIF1A (0.41) ALDH1A1MAPTHPGDTSHR
SCHEMBL1715217 0.78 ALDH1A1 (0.42) ALDH1A1MAPTHPGDTSHR
SCHEMBL1714901 0.78 MAPT (0.39) ALDH1A1MAPTHPGDTSHR
SCHEMBL1714645 0.77 ALDH1A1 (0.50) ALDH1A1MAPTTSHR
SCHEMBL1714636 0.77 MAPT (0.38) ALDH1A1MAPTTSHR
SCHEMBL1715063 0.77 MAPT (0.38) ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7368604-B2 Method for the production of acylphosphine oxides BASF AKTIENGESELLSCHAFT (DE) 2008-05-06 US claimed
EP-1546163-B1 METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES BASF AG (DE) 2006-07-12 EP claimed
US-20060052636-A1 Method for the production of acylphosphine oxides BASF AKTIENGESELLSCHAFT (DE) 2006-03-09 US claimed
CN-107001654-B Method for curing curable composition 巴斯夫欧洲公司 2020-11-20 CN disclosed
US-10577471-B2 Method for curing curable compositions BASF SE (DE) 2020-03-03 US disclosed
EP-3201261-B1 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2018-12-12 EP disclosed
US-20180148554-A9 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2018-05-31 US disclosed
US-9840635-B2 Binding agent systems CONSTRUCTION RESEARCH & TECHNOLOGY, GMBH (DE) 2017-12-12 US disclosed
US-20170306118-A1 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2017-10-26 US disclosed
EP-3201261-A1 METHOD FOR CURING CURABLE COMPOSITIONS BASF SE (DE) 2017-08-09 EP disclosed
EP-3066161-B1 COATINGS FOR USE AS ADHESIVE CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2017-07-05 EP disclosed
US-20070167653-A1 Method for producing acylphosphine oxide solids BASF AKIENGESELLSCHAFT (DE) 2007-07-19 US disclosed
US-20070135556-A1 Coating materials containing alpha-(1'-hydroxyalkyl)acrylates BASF AKTIENGESELLSCHAFT (DE) 2007-06-14 US disclosed
EP-1546163-B1 METHOD FOR THE PRODUCTION OF ACYLPHOSPHINE OXIDES BASF AG (DE) 2006-07-12 EP disclosed
US-20060052636-A1 Method for the production of acylphosphine oxides BASF AKTIENGESELLSCHAFT (DE) 2006-03-09 US disclosed
EP-1613638-A2 METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS BASF AKTIENGESELLSCHAFT (DE) 2006-01-11 EP disclosed
US-20050222294-A1 Acyl- and bisacylphosphine derivatives IGM GROUP B.V. (NL) 2005-10-06 US disclosed
WO-2004094439-A2 METHOD FOR THE PRODUCTION OF ACYLPHOSPHINES BASF AKTIENGESELLSCHAFT (DE) 2004-11-04 WO disclosed
WO-2004087723-A2 METHOD FOR PRODUCING ACYLPHOSPHINE OXIDE SOLIDS BASF AKTIENGESELLSCHAFT (DE) 2004-10-14 WO disclosed
US-20040116702-A1 Alkoxylated acyl-and bisacylphoshine derivatives BASF AKTIENGESELLSCHAFT (DE) 2004-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167653-A1 Method for producing acylphosphine oxide solids AGPAT5, PHOSPHO1, AGPS ALDH1A1 4412/4885MAPT 2168/4885HPGD 3436/4885
US-20060052636-A1 Method for the production of acylphosphine oxides AGPAT5, PNPO, PHOSPHO1 ALDH1A1 2749/4885MAPT 3413/4885HPGD 2190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.